TY - STD TI - Hu Z, Ott PA, Wu CJ. Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nat. Publ. Gr. [Internet]. Nature Publishing Group; 2017; Available from: https://doi.org/10.1038/nri.2017.131 ID - ref1 ER - TY - STD TI - Aurisicchio L, Pallocca M, Ciliberto G, Palombo F. The perfect personalized cancer therapy: cancer vaccines against neoantigens. J Exp Clin Cancer Res; 2018;37:86. Available from: https://doi.org/10.1186/s13046-018-0751-1 ID - ref2 ER - TY - STD TI - Strønen E, Toebes M, Kelderman S, Van BMM, Yang W, Van RN, et al. Targeting of cancer neoantigens with donor-derived T cell receptor repertoires(1). 2016;2288:1–11. ID - ref3 ER - TY - STD TI - Ott PA, Hu Z, Keskin DB, Shukla SA, Sun J, Bozym DJ, et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature [internet]. Nat Publ Group; 2017;547:217–221. Available from: https://doi.org/10.1038/nature22991 ID - ref4 ER - TY - JOUR AU - Sahin, U. AU - Derhovanessian, E. AU - Miller, M. AU - Kloke, B. P. AU - Simon, P. AU - Löwer, M. PY - 2017 DA - 2017// TI - Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature [internet] JO - Nat Publ Group VL - 547 UR - https://doi.org/10.1038/nature23003 DO - 10.1038/nature23003 ID - Sahin2017 ER - TY - JOUR AU - Castle, J. C. AU - Kreiter, S. AU - Diekmann, J. AU - Löwer, M. AU - Roemer, N. AU - Graaf, J. PY - 2012 DA - 2012// TI - Exploiting the mutanome for tumor vaccination JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3722 DO - 10.1158/0008-5472.CAN-11-3722 ID - Castle2012 ER - TY - STD TI - Aurisicchio L, Fridman A, Bagchi A, Scarselli E, La Monica N, Ciliberto G. A novel minigene scaffold for therapeutic cancer vaccines. Oncoimmunology [Internet]. 2014;3:e27529. Available from: http://www.tandfonline.com/doi/full/10.4161/onci.27529 UR - http://www.tandfonline.com/doi/full/10.4161/onci.27529 ID - ref7 ER - TY - STD TI - Pierini S, Perales-Linares R, Uribe-Herranz M, Pol JG, Zitvogel L, Kroemer G, et al. Trial watch: DNA-based vaccines for oncological indications. Oncoimmunology. Taylor & Francis; 2017;6:1–17. Available from: https://doi.org/10.1080/2162402X.2017.1398878. ID - ref8 ER - TY - STD TI - Kreiter S, Vormehr M, van de Roemer N, Diken M, Löwer M, Diekmann J, et al. Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature [Internet]. 2015;520:692–6. Available from: https://www.nature.com/articles/nature14426. UR - https://www.nature.com/articles/nature14426 ID - ref9 ER - TY - JOUR AU - Kranz, L. M. AU - Diken, M. AU - Haas, H. AU - Kreiter, S. AU - Loquai, C. AU - Reuter, K. C. PY - 2016 DA - 2016// TI - Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy JO - Nature VL - 534 UR - https://doi.org/10.1038/nature18300 DO - 10.1038/nature18300 ID - Kranz2016 ER - TY - STD TI - Duan F, Duitama J, Al Seesi S, Ayres CM, Corcelli SA, Pawashe AP, et al. Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity. J Exp Med. 2014;211:2231–48. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203949/. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203949/ ID - ref11 ER - TY - STD TI - Snyder A, Makarov V, Merghoub T, Yuan J, Zaretsky JM, Desrichard A, et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N Engl J Med. 2014;2189–99. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315319/. UR - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315319/ ID - ref12 ER - TY - JOUR AU - Balachandran, V. P. AU - Luksza, M. AU - Zhao, J. N. AU - Makarov, V. AU - Moral, J. A. AU - Remark, R. PY - 2017 DA - 2017// TI - Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer JO - Nature England VL - 551 ID - Balachandran2017 ER - TY - STD TI - Yadav M, Jhunjhunwala S, Phung QT, Lupardus P, Tanguay J, Bumbaca S, et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature [Internet]. 2014;515:572–6. Available from: http://www.nature.com/doifinder/10.1038/nature14001%5C. UR - http://www.nature.com/doifinder/10.1038/nature14001%5C ID - ref14 ER - TY - STD TI - Folgiero V, Sorino C, Pallocca M, De Nicola F, Goeman F, Bertaina V, et al. Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia. EMBO Rep England. 2018;19. ID - ref15 ER - TY - JOUR AU - Marco, M. AU - Astolfi, A. AU - Grassi, E. AU - Vecchiarelli, S. AU - Macchini, M. AU - Indio, V. PY - 2015 DA - 2015// TI - Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array JO - Mol Med Rep VL - 12 UR - https://doi.org/10.3892/mmr.2015.4344 DO - 10.3892/mmr.2015.4344 ID - Marco2015 ER - TY - STD TI - Garrison E. Marth G. Haplotype-based variant detection from short-read sequencing. 2012:1–9 Available from: http://arxiv.org/abs/1207.3907. UR - http://arxiv.org/abs/1207.3907 ID - ref17 ER - TY - JOUR AU - Nielsen, M. AU - Lundegaard, C. AU - Worning, P. AU - Lauemoller, S. L. AU - Lamberth, K. AU - Buus, S. PY - 2003 DA - 2003// TI - Reliable prediction of T-cell epitopes using neural networks with novel sequence representations JO - Protein Sci United States VL - 12 UR - https://doi.org/10.1110/ps.0239403 DO - 10.1110/ps.0239403 ID - Nielsen2003 ER - TY - JOUR AU - Mennuni, C. AU - Calvaruso, F. AU - Facciabene, A. AU - Aurisicchio, L. AU - Storto, M. AU - Scarselli, E. PY - 2005 DA - 2005// TI - Efficient induction of T-cell responses to carcinoembryonic antigen by a heterologous prime-boost regimen using DNA and adenovirus vectors carrying a codon usage optimized cDNA JO - Int J Cancer VL - 117 UR - https://doi.org/10.1002/ijc.21188 DO - 10.1002/ijc.21188 ID - Mennuni2005 ER - TY - JOUR AU - Elia, L. AU - Mennuni, C. AU - Storto, M. AU - Podda, S. AU - Calvaruso, F. AU - Salucci, V. PY - 2006 DA - 2006// TI - Genetic vaccines against ep-CAM break tolerance to self in a limited subset of subjects: initial identification of predictive biomarkers JO - Eur J Immunol VL - 36 UR - https://doi.org/10.1002/eji.200535514 DO - 10.1002/eji.200535514 ID - Elia2006 ER - TY - JOUR AU - Roscilli, G. AU - Vitis, C. AU - Ferrara, F. F. AU - Noto, A. AU - Cherubini, E. AU - Ricci, A. PY - 2016 DA - 2016// TI - Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity JO - J Transl Med VL - 14 UR - https://doi.org/10.1186/s12967-016-0816-x DO - 10.1186/s12967-016-0816-x ID - Roscilli2016 ER - TY - JOUR AU - Euw, E. AU - Atefi, M. AU - Attar, N. AU - Chu, C. AU - Zachariah, S. AU - Burgess, B. L. PY - 2012 DA - 2012// TI - Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines JO - Mol Cancer VL - 11 UR - https://doi.org/10.1186/1476-4598-11-1 DO - 10.1186/1476-4598-11-1 ID - Euw2012 ER - TY - JOUR AU - Kuai, R. AU - Ochyl, L. J. AU - Bahjat, K. S. AU - Schwendeman, A. AU - Moon, J. J. PY - 2017 DA - 2017// TI - Designer vaccine nanodiscs for personalized cancer immunotherapy JO - Nat Mater England VL - 16 UR - https://doi.org/10.1038/nmat4822 DO - 10.1038/nmat4822 ID - Kuai2017 ER - TY - JOUR AU - Teku, G. N. AU - Vihinen, M. PY - 2018 DA - 2018// TI - Pan-cancer analysis of neoepitopes JO - Sci Rep Springer US VL - 8 ID - Teku2018 ER - TY - STD TI - Eggermont AMM, Blank CU, Mandala M, Long G V, Atkinson V, Dalle S, et al. Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma. N Engl J Med. 2018;NEJMoa1802357. Available from: http://www.nejm.org/doi/10.1056/NEJMoa1802357 UR - http://www.nejm.org/doi/10.1056/NEJMoa1802357 ID - ref25 ER - TY - JOUR AU - Eggermont, A. M. M. AU - Chiarion-Sileni, V. AU - Grob, J. J. AU - Dummer, R. AU - Wolchok, J. D. AU - Schmidt, H. PY - 2015 DA - 2015// TI - Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)70122-1 DO - 10.1016/S1470-2045(15)70122-1 ID - Eggermont2015 ER - TY - JOUR AU - Tran, E. AU - Robbins, P. F. AU - Rosenberg, S. A. PY - 2017 DA - 2017// TI - Final common pathway’ of human cancer immunotherapy: targeting random somatic mutations JO - Nat Immunol VL - 18 UR - https://doi.org/10.1038/ni.3682 DO - 10.1038/ni.3682 ID - Tran2017 ER - TY - STD TI - Martin SD, Brown SD, Wick DA, Nielsen JS, Kroeger R. Twumasi-boateng K, et al. Low Mutation Burden in Ovarian Cancer May Limit the Utility of Neoantigen-Targeted Vaccines. 2016:1–22. Available from:. https://doi.org/10.1371/journal.pone.0155189. ID - ref28 ER - TY - STD TI - Bobisse S, Genolet R, Roberti A, Tanyi JL, Racle J, Stevenson BJ, et al. Sensitive and frequent identification of high avidity neo-epitope specific CD8+T cells in immunotherapy-naive ovarian cancer. Nat Commun [internet]. Springer US; 2018;9:1–10. Available from: https://doi.org/10.1038/s41467-018-03301-0 ID - ref29 ER - TY - STD TI - Mcgranahan N, Furness AJS, Rosenthal R, Ramskov S, Lyngaa R, Saini SK, et al. Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade. Science (80-. ). [Internet]. 2016;351:1463–9. Available from: http://www.sciencemag.org/cgi/doi/10.1126/science.aaf1490 UR - http://www.sciencemag.org/cgi/doi/10.1126/science.aaf1490 ID - ref30 ER - TY - STD TI - Yarchoan M, Johnson BA 3rd, Lutz ER, Laheru DA, Jaffee EM. Targeting neoantigens to augment antitumour immunity. Nat Rev Cancer England; 2017;17:209–222. ID - ref31 ER - TY - STD TI - Bassani-Sternberg M, Bräunlein E, Klar R, Engleitner T, Sinitcyn P, Audehm S, et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat. Commun. [Internet]. 2016;7:13404. Available from: http://www.nature.com/doifinder/10.1038/ncomms13404 UR - http://www.nature.com/doifinder/10.1038/ncomms13404 ID - ref32 ER - TY - STD TI - Peruzzi D, Gavazza A, Mesiti G, Lubas G, Scarselli E, Conforti A, et al. A vaccine targeting telomerase enhances survival of dogs affected by B-cell lymphoma. Mol. Ther. [internet]. Nat Publ Group; 2010;18:1559–67. Available from: https://doi.org/10.1038/mt.2010.104 ID - ref33 ER - TY - STD TI - Carreno BM, Magrini V, Becker-Hapak M, Kaabinejadian S, Hundal J, Petti AA, et al. Cancer immunotherapy. A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells. Science (80-. ). [internet]. 2015;348:803–8. Available from: http://science.sciencemag.org/content/348/6236/803.long. UR - http://science.sciencemag.org/content/348/6236/803.long ID - ref34 ER -